Bionexus Gene Lab CORP (BGLC) — 10-Q Filings

10-Q Filings (6)

• BioNexus Narrows Q3 Loss, But 9-Month Deficit Widens Amid Revenue Dip — Nov 14, 2025 Risk: high
  BioNexus Gene Lab Corp. (BGLC) reported a net loss of $708,991 for the three months ended September 30, 2025, a significant improvement from the $1,345,370 net
• BioNexus Gene Lab Corp Q2 2025 10-Q Filed — Aug 18, 2025 Risk: medium
  BioNexus Gene Lab Corp filed a 10-Q for the period ending June 30, 2025. The company, incorporated in Wyoming, operates in medical laboratories and is based in
• BioNexus Gene Lab Corp Q1 2025 10-Q Filing — May 15, 2025 Risk: medium
  BioNexus Gene Lab Corp filed a 10-Q for the period ending March 31, 2025. The company's business activities include investment holding and provision for genomic
• BioNexus Gene Lab Corp Files Q3 2024 10-Q — Nov 15, 2024 Risk: medium
  BioNexus Gene Lab Corp filed its Q3 2024 10-Q report on November 15, 2024, covering the period ending September 30, 2024. The company, incorporated in Wyoming,
• BioNexus Gene Lab Corp Files Q2 2024 10-Q — Aug 14, 2024 Risk: low
  BioNexus Gene Lab Corp filed its 10-Q for the period ending June 30, 2024. The company, incorporated in Wyoming, operates in the medical laboratories sector. It
• BioNexus Gene Lab Corp Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  BioNexus Gene Lab Corp (BGLC) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. BioNexus Gene Lab Corp filed a 10-Q report for the period ending Mar

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX